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Abstract Many mutations in the human tumor suppressor p53
a¡ect the function of the protein by destabilizing the structure of
its DNA binding domain. To monitor the e¡ects of those muta-
tions in vivo the stability of the DNA binding domain of p53 and
some of its mutants was investigated with the split-ubiquitin
(split-Ub) method. The split-Ub-derived in vivo data on the rel-
ative stability of the mutants roughly correlate with the quanti-
tative data from in vitro denaturation experiments as reported in
the literature. A variation of this assay allows visualizing the
di¡erence in stability between the wild-type p53 core and the
mutant p53V143A by a simple growth assay.
) 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The protein p53 is a transcriptional activator that controls
tumor suppression and apoptosis in higher eukaryotes [1]. Its
role in tumor suppression is highlighted by the fact that ap-
proximately 50% of all human cancers display a mutation in
the protein p53. Most of those mutations fall into the central
DNA binding domain and can be roughly divided into muta-
tions that directly a¡ect the DNA binding properties and
mutations that destabilize or distort the structure of the pro-
tein and thereby a¡ect the DNA binding properties of the
protein more indirectly. Assays that can distinguish between
those two classes are therefore important in developing and
monitoring the action of new chemicals that aim to stabilize
p53 and its mutants [2]. Measuring the stability of p53 in-
volves either purifying the core domain and recording its
urea-induced denaturation curve or the use of conformation-
sensitive antibodies [3,4]. Whereas the former technique re-
quires puri¢ed proteins and provides very accurate and quan-
titative data, the latter technique also works in extracts but
does not allow a quanti¢cation of the measured e¡ects. How-
ever, both techniques ignore the in£uence of cellular factors
on the folding or the stability of the protein. Since p53 and
some of its mutants were reported to associate with heat
shock proteins to di¡erent extents both approaches might be
of limited use for evaluating the structural state of p53 in
living cells [5,6]. The same argument would also favor cell-
based over pure in vitro assays to monitor the in£uence of
candidate compounds on the stability of the p53 core domain.
To explore alternative ways to measure the stability of p53
and its mutants in living cells I made use of a modi¢cation of
the split-ubiquitin system (split-Ub).
The split-Ub method is based on the ability of Nub and Cub,
the N- and C-terminal halves of Ub, to assemble into a qua-
sinative Ub. Ub-speci¢c proteases recognize the reconstituted
Ub, though not its halves, and cleave the Ub moiety o¡ a
reporter protein which has been linked to the C-terminus of
Cub. The release of the reporter serves as readout indicating
the reconstitution of Ub. The assay is designed in a way that
prevents e⁄cient association of Nub and Cub by themselves,
but permits such association if the two Ub halves are sepa-
rately linked to proteins that interact in vivo [7]. Attaching
Nub and Cub to the N- and C-terminus of the same polypep-
tide makes possible the measurement of intramolecular Nub
and Cub reassociation by quantifying the ratio of cleaved to
uncleaved fusion protein possible. This ratio is de¢ned both
by the a⁄nity of Nub to Cub, as well as by the nature of the
polypeptide separating Nub from Cub. For example, if the
protein adopts a folded conformation where the N- and the
C-terminus are in close proximity, the intramolecular associ-
ation of Nub and Cub and the subsequent cleavage is favored
compared to an unfolded conformation. The assay was used
to monitor the conformational change of the Q-subunit of the
trimeric G-protein upon binding its L-subunit and to follow
the e¡ect of a mutation onto the conformation of the N-ter-
minal domain of Sec62p [8,9]. Here I developed the technique
into an assay that can distinguish between mutants of p53 that
disturb the structure of the protein from those that directly
interfere with its DNA binding activity.
2. Materials and methods
2.1. Construction of fusion proteins
Fragments encoding the open reading frame (ORF) of p53, p53v,
V143A or the mutant [S135Y; S240I] were obtained by PCR using
plasmids encoding the full-length ORFs as a template and an oligo-
nucleotide primer complementary to the 5P- and 3P-ends of the core
domain respectively. All 5P-primers contained an additional BamHI
site and all 3P-primers an additional SalI site to allow for the in-frame
fusion with the Nub and Cub moieties. The region connecting the se-
quence of Nub to the sequence of the core domain of p53 reads: GGG
ATC CCT GGG GAT ACC. The BamHI site is underlined and the
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last codon of the Nub and the ¢rst residue of p53C (T102) are in bold
letters. The sequence connecting the end of p53C to the sequence of
Cub reads: GGG TCG ACC GGT. The SalI site is underlined. The
last codon of p53C (G 293) and the ¢rst codon of Cub are in bold
letters. The obtained PCR fragments were cut with BamHI and SalI
and introduced into the correspondingly cut PCUP1-Nub-Cub-Dha (di-
hydrofolate reductase extended by the hemagglutinin epitope) cassette
on a pRS314 vector. All other mutations were introduced by site-
directed mutagenesis using the Quick-change protocol from Strata-
gene (Amsterdam, The Netherlands).
The oligonucleotides used for the mutagenesis read: R175H
forward: ACGGAGGTTGTGAGGCACTGCCCCCACCATGAG;
R175H reverse: CTCATGGTGGGGGCAGTGCCTCACAACCTC-
CGT; C242S forward: CATGTGTAACAGTTCCTCCATGGGCG-
GCATGAACC; C242S reverse: GGTTCATGCCGCCCATGGAG-
GAACTGTTACACATG; R248Q forward: ATGGGCGGCATGA-
ACCAGAGGCCCATCCTCACC; R248Q reverse: GGTGAGGAT-
GGGCCTCTGGTTCATGCCGCCCAT; R273H forward: CGGA-
ACAGCTTTGAGGTGCATGTTTGTGCCTGTCCTGGG; R273H
reverse: CCCAGGACAGGCACAAACATGCACCTCAAAGCTG-
TTCCG; N268D forward: AATCTACTGGGACGGGACAGCTTT-
GAGGTGCGT; N268D reverse: ACGCACCTCAAAGCTGTCCC-
GTCCCAGTAGATT.
The corresponding Cub-RURA3 constructs were obtained by insert-
ing the EagI^SalI cut PCUP1-Nub ORF in front of the Cub-RURA3
module on a pRS313 vector.
DNA sequences were determined by the MPIZ DNA facility on PE
Biosystems ABI Prism 377 and 3700 sequencers using BigDye-termi-
nator chemistry. Oligonucleotides were purchased from Metabion
(Martinsried, Germany).
2.2. Immunoblotting
Saccharomyces cerevisiae cells expressing the di¡erent Nub-p53C-
Cub-Dha were grown at 30‡C in 10 ml of SD medium to an optical
density at 600 nm (OD600) of V0.8 and supplemented with 100 WM
CuSO4 and when indicated shifted to 37‡C 1 h prior to cell extraction.
Cell extraction for immunoblotting was performed essentially as pre-
viously described [10]. Proteins were fractionated by SDS^12.5%
PAGE and electroblotted onto nitrocellulose membranes (Schlei-
cherpSchuell, Dassel, Germany), using a semi-dry transfer system
(Hoefer, Pharmacia Biotech Inc., San Francisco, CA, USA). Blots
were incubated with a monoclonal anti-hemagglutinin (HA) antibody
(Babco, Richmond, CA, USA). Bound antibody was visualized with
horseradish peroxidase-coupled rabbit anti-mouse (Bio-Rad, Her-
cules, CA, USA), using the chemiluminescence detection system
(Pierce, Rockford, IL, USA). The chemiluminescence was quanti¢ed
with the aid of the lumi-imager system (Boehringer, Mannheim, Ger-
many).
2.3. Yeast strains, growth and functionality assays
S. cerevisiae strains were JD53 (MATK his3-v200 leu2-3,112 lys2-
801 trp1-v63 ura3-52), yeast rich (YPD) and synthetic minimal media
with 2% dextrose (SD) or 2% galactose (SG) followed standard rec-
ipes.
Growth assays: S. cerevisiae cells were ¢rst grown at 30‡C in liquid
selective media containing uracil. Cells were diluted in water to an
OD600 of 1 and 4 Wl were spotted on agar plates selecting for the
presence of the fusion constructs and containing 5-FOA at a concen-
tration of 1 mg/ml. The plates were incubated at 30‡C for 3.5 days.
3. Results
3.1. Monitoring the in£uence of mutations on the structure of
p53 in vivo
The mean spatial distance between the N- and the C-termi-
nus in a protein depends on their spatial arrangement and on
the stability and rigidity of the folded structure. Mutations
that change the stability or the conformation of the protein
will therefore alter this distance [11]. The reassociation of Nub
and Cub that are attached to the N- and C-terminus of the
core domain of p53 (p53C) should be a sensitive measure of
monitoring such changes in p53 in living cells (Fig. 1). Ac-
cording to the extent of the Nub^Cub reassociation the assay
should allow classifying the mutations occurring in p53 into
two groups. Native p53 and those mutants that only a¡ect the
DNA binding should share very similar ratios of cleaved to
uncleaved Nub-p53C-Cub reporter whereas structurally desta-
bilizing mutations should alter this ratio (Fig. 1).
To test this concept I ¢rst studied a mutation that most
probably should unfold p53C under physiological conditions.
A deletion of 28 residues between positions 115 and 143 of the
full-length protein removes the L1 loop and the S2^S2P hair-
pin L-sheet to yield p53v. Since the deleted regions contain
central structural elements of p53C, p53v should be com-
pletely unfolded [12].
The central DNA binding domains of native p53C and p53v
(residues 102^293) were introduced between the N- and the C-
terminal half of Ub (Nvg and Cub). Nvg is a mutant of the
wild-type Nub that binds with a reduced a⁄nity to Cub [9].
Fig. 1. Rational of the split-Ub assay. A: The majority of p53C is folded (closed circle) under physiological conditions as indicated by length
of the arrows (1) and the e⁄ciency of reassociation of the attached Nub and Cub is dictated by the arrangement of the N- and C-terminus in
the folded structure (2). The reassociation of Nub and Cub is monitored by the cleavage and release of the reporter protein R. B: A mutation
that destabilizes the structure of p53 will shift the equilibrium to a higher proportion of unfolded molecules as indicated by the lengths of the
arrows (1). The reassociation of the attached Nub and Cub is now dominated by the mean distance of the N- and C-terminus in the denatured
state (wavy line). Provided that the rates of Nub^Cub reassociation are di¡erent between the folded and the unfolded conformations as indicated
by the length of the arrows (2) and (3), the in£uence of a mutation on the stability of p53C can be measured by the altered ratio of the cleaved
to uncleaved fusion protein (here the ratio of cleaved to uncleaved p53 fusion protein is decreased by the mutation).
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The Cub moiety was extended with the mouse dihydrofolate
reductase that contains a HA-tag at its C-terminus (Dha) to
create Nvg-p53C-Cub-Dha and Nvg-p53v-Cub-Dha respectively.
The expression of the fusion proteins was induced in yeast
cells for 1 h at 37‡C or 30‡C and the ratio of cleaved to
uncleaved fusion protein was determined by Western blotting.
The inspection of the anti-HA Western blot reveals a clear
di¡erence in cleavage between Nvg-p53C-Cub-Dha and its mu-
tant (Fig. 2). Whereas 77% of Nvg-p53C-Cub-Dha are cleaved
at 30‡C, a majority of 85% of Nvg-p53v-Cub-Dha remains
uncleaved at this temperature. I conclude that upon unfolding
of the core domain the spatial distance between the N- and
the C-terminus of the polypeptide increases. To support this
conclusion another mutant of p53 that should not adopt a
folded structure was constructed. In this mutant a bulky ty-
rosine replaces the natural cysteine at position 135 (all num-
bers relate to the residue position in the full-length p53) and a
hydrophobic leucine replaces the conserved serine at position
240 ([C135Y; S240I]). As observed for p53v the majority of
the expressed Nvg-[C135Y; S240I]-Cub-Dha remains uncleaved
(Fig. 2A, lane 3). The very similar ratio of cleaved to un-
cleaved fusion protein suggests that both mutants of p53 are
equally unfolded (Fig. 2A). In Fig. 2B the e¡ect of a certain
mutation onto the stability of the p53C is given as relative
destabilization. This value is calculated for each mutant by
subtracting the percentage of cleaved Nvg-p53CMut-Cub-Dha
from the percentage of cleaved Nvg-p53C-Cub-Dha. By extrap-
olating the results of p53v and [C135Y; S240I] a positive
value will re£ect a reduced stability of the mutant p53. A
value close to zero will indicate a similar stability as the
wild-type p53 whereas a negative value will indicate a higher
stability of the mutant. To validate this interpretation and to
compare their conformational properties in vivo I measured
the cleavage ratios of ¢ve further p53 mutants that are known
to be associated with cancer. The urea denaturation curves of
these ¢ve mutants were precisely determined and their degree
of unfolding extrapolated to more physiological conditions at
37‡C [13]. The mutant R273H harbors a histidine instead of
an arginine in position 273. R273 protrudes into the solvent
and is directly involved in DNA recognition [12]. The global
stability of the mutant is only marginally decreased. As can be
seen in Fig. 2A,B the cleavage of the Nub-R273H-Cub-Dha is
nearly identical to that of Nub-p53C-Cub-Dha at both temper-
atures measured. The assay therefore correctly con¢rms that
the R273H exchange does not impair the stability of the pro-
tein.
The R248Q exchange is one of the more frequently ob-
served mutations in p53-ssociated tumors. The arginine in
positions 248 directly contacts the DNA and is fully exposed
[12]. Urea denaturation experiments revealed a decrease in
stability of 1.9 kcal/mol compared to the wild-type protein.
This decrease translates into an estimated 14% of unfolded
molecules at 37‡C [13]. In accordance with this relatively small
percentage of unfolded molecules I observe no signi¢cant dif-
ference between the wild-type protein and R248Q in the cleav-
age of the respective fusion proteins at 30‡C. However, at
37‡C the mutant yields in average a higher fraction of cleaved
Dha indicating a slight stabilization relative to wild-type. This
interpretation contradicts the reported in vitro stability mea-
surements. Despite this discrepancy the assay con¢rms that
the R248Q mutation does not exert its e¡ect via a global
destabilization of p53C.
Fig. 2. Measuring the e¡ects of cancer-causing mutations on the
stability of p53C in vivo. A: Nvg-p53C-Cub-Dha and di¡erent p53C
mutants were expressed in yeast at 37‡C and the cleaved and un-
cleaved fractions of the fusion proteins were probed with the anti-
HA antibody on a nitrocellulose blot after cell extraction and SDS^
PAGE. The amount of cleaved and uncleaved fusion protein was
measured by quantitative chemoluminescence. The amino acid ex-
changes of the di¡erent p53C mutants are indicated at the top of
the blot. A stretch of 28 amino acids of p53C is missing in v. B:
Summary of the e¡ect of di¡erent mutations on the stability of
p53C. For each experiment the percentage of cleaved Nvg-p53C-Cub-
Dha was calculated. This value was subtracted from the percentage
of cleaved Nvg-p53C-Cub-Dha of the di¡erent mutants to give the
value of relative destabilization. A positive value, indicating a higher
fraction of uncleaved fusion protein, indicates destabilization of the
mutant protein whereas a negative value indicating a higher fraction
of cleaved Dha indicates stabilization of p53C. Experiments were
performed at 30‡C (black bars) and 37‡C (gray bars). Five indepen-
dent experiments at each temperature are shown except for C242S
(four experiments at 37‡C) and R175H (six experiments at 37‡C).
C: Correlation between the split-Ub-derived values of relative desta-
bilization and the calculated fraction of unfolded molecules at 37‡C
according to Bullock et al. [12].
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Other known mutants primarily disturb the structure of p53
or reduce the stability of the protein. P53 binds zinc and this
binding stabilizes the core. I tested two known cancer-causing
mutants of p53C that both destroy the ability of p53 to bind
zinc [12]. As a consequence both mutants are less stable than
the wild-type protein by 3.5 (R175H) and 3.1 (C242S) kcal/
mol respectively [13]. At 30‡C the two mutants and the native
p53C give nearly identical cleavage ratios whereas at 37‡C
R175H and C242S can be distinguished from the wild-type
core by an increase in the amount of uncleaved fusion protein
(Fig. 2). In accordance with the literature the values of a rel-
ative destabilization of +12 indicate that both mutants display
a higher proportion of unfolded molecules at 37‡C.
The V143A exchange a¡ects the stability of the core by 3.5
kcal/mol [13]. This destabilization is clearly re£ected in the
split-Ub assay by the relatively small fraction of cleaved
Nvg-V143A-Cub-Dha at 30‡C and at 37‡C resulting in a value
of relative destabilization of +42 and +27 respectively (Fig. 2).
A second side mutation in position 268 (N268D) restores
some of the functions of V143A at 30‡C [14]. I constructed
Nvg-[V143A; N268D]-Cub-Dha to test if the in vivo assay
reveals a stabilization of the conformation of V143A by the
additional N268D exchange. At 30‡C Nvg-[V143A; N268D]-
Cub-Dha has a higher fraction of cleaved Dha than the single
mutant Nvg-V143A-Cub-Dha. This decrease in relative desta-
bilization clearly indicates a higher stability of the double mu-
tant [V143A; N268D] compared to the single mutant V143A
[15]. However, the di¡erence between the two mutants dis-
appears when the values of relative destabilization of Nvg-
[V143A; N268D]-Cub-Dha and Nvg-V143A-Cub-Dha are com-
pared at 37‡C (Fig. 2).
To measure the in£uence of the single N268D exchange on
the stability of the wild-type core of p53 I performed the split-
Ub assay of Nvg-N268D-Cub-Dha. At 30‡C the cleavage rate
of Nvg-N268D-Cub-Dha is nearly identical to that of the wild-
type core. At 37‡C the value of relative destabilization of 310
indicates an increase in the conformational stability of
N268D. One should note that the assay would detect an in-
crease in stability of a mutant only if a signi¢cant fraction of
the wild-type p53C already unfolds at 37‡C in the Nub-p53C-
Cub-Dha fusion protein. This might explain why the e¡ect of
the N268D mutation is only seen at 37‡C.
In Fig. 2C I plotted the values of relative destabilization for
the di¡erent p53 mutations at 37‡C as measured and calcu-
lated by the split-Ub technique against the proportion of un-
folded molecules as calculated by Bullock et al. [13]. I as-
sumed that a value of relative destabilization of +45 (p53v
and [C135Y; S240I]) re£ects the completely unfolded popula-
tion of molecules. I further assumed that the split-Ub-derived
value for destabilization linearly correlates with the propor-
tion of unfolded molecules of the mutants as calculated by
Bullock et al. on the basis of their equilibrium measurements
of the same mutants [13]. In agreement with these two as-
sumptions the two sets of data correlate (Fig. 2C). The graph
intercepts the y-axis at a value of 20% of unfolded molecules
as if p53C in the fusion protein is already partially unfolded
under physiological conditions.
3.2. A cell-based growth assay to monitor the structure of the
p53 core
Compounds that stabilize the conformation of p53 are dis-
cussed as possible drugs for the treatment of cancers that are
associated with mutations in p53 [2,16]. It is therefore desir-
able to develop cell-based assays that allow testing for such
compounds [17]. Towards this end I exchanged the Dha re-
porter against the RUra3p reporter to create Nub-p53C-Cub-
RUra3p. Since cleavage exposes an arginine at the N-terminus
of RUra3p the freed reporter is targeted for rapid destruction
via the N-end rule pathway [18,19]. Cells expressing fusion
proteins that are completely cleaved do not grow on Sd-ura
but will grow on medium containing the substance 5-FOA
since Ura3p that otherwise would convert 5-FOA to the toxic
5-F-uracil is rapidly degraded. Mutations in p53 that substan-
tially increase the amount of uncleaved fusion protein will
increase the Ura3p activity and will cause the cells to die on
medium containing 5-FOA. To test the feasibility of this ap-
proach I focused on the V143A mutant since this mutation
exclusively a¡ects the stability of p53 to an extent that can be
easily measured by the split-Ub assay at 37‡C as well as 30‡C.
To be able to detect an alteration in the growth of the cells
requires that the majority of the RUra3p have to be cleaved
o¡ from the Cub and degraded. Since Nvg-p53C-Cub-Dha
leaves a signi¢cant fraction of the fusion protein uncleaved
di¡erent Nub mutants with a higher a⁄nity to Cub than Nvg
were tested [8,9]. Cells expressing either wild-type p53C or
V143A in di¡erent Nix-p53C-Cub-RUra3 fusions were spotted
on medium containing 5-FOA. As can be seen in Fig. 3C, the
cells containing the Nia and to a lesser extent the cells con-
taining the Nig distinguish between wild-type p53C and the
mutant V143A. The cells containing the wild-type p53C
grow whereas the cells containing the mutant V143A die. A
similar experiment using the same Nub mutants but the Dha
as a reporter con¢rmed the growth assay by a cell extraction
and Western blotting experiment. All constructs containing
the wild-type protein gave a higher proportion of cleaved
fusion protein than the V143A mutant independent of the
Nub that was used for the assay (Fig. 3). Importantly, the
di¡erence in growth between the cells containing the Nia-
p53C-Cub-RUra3p constructs is not due to a di¡erence in
the steady state expression of the fusion as the sums of
cleaved and uncleaved Nia-p53C-Cub-Dha fusions of the
wild-type and the V143A mutant are very similar (Fig. 3A).
4. Discussion
To monitor the molecular defects of some of the cancer-
causing mutants of p53 in a cellular environment, I used the
split-Ub technique to measure the mutation-induced altera-
tion in the stability of the DNA binding domain of p53.
The comparison with the published thermodynamic data al-
lowed evaluating the predictive and quantitative value of this
technique. The application of the RUra3p reporter made it
possible to monitor the reduced stability of the V143A mutant
by a simple growth assay of the yeast expressing the respective
fusion proteins.
The application of the split-Ub assay on the analysis of the
mutations in p53 rested on two prerequisites. First, the un-
folding of p53C had to alter the cleavage of the corresponding
Nub-p53C-Cub fusion protein. Secondly, the amount of unfold-
ing must correspond to the change in the ratio of cleaved to
uncleaved fusion protein. The mutants p53v and [C135Y;
S240I] served as a reference for the unfolded state of p53C.
Both mutants displayed a signi¢cant decrease in the ratio of
cleaved to uncleaved fusion protein. A correlation between the
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fraction of unfolded polypeptides and the reduction in cleav-
age (expressed in relative destabilization) of the corresponding
Nub-p53C-Cub-Dha of the other tested mutants was therefore
postulated. Fig. 2D con¢rms this assumption by showing a
correlation between the two data sets. However, two of the
tested single mutants stand out in deviating from the expec-
tation. R248Q is destabilized by 1.9 kcal/mol at 37‡C yet has a
smaller value of relative destabilization in the assay than the
wild-type p53C (Fig. 2A,B). R175H leads to the predicted
reduction in cleavage of the fusion protein. However, the
amount of the relative destabilization is much smaller than
the value for V134A, although both mutants display very
similar denaturation curves in the in vitro experiment [13].
A realization of the inherent limitations of the split-Ub tech-
nique might help to understand these discrepancies. The assay
relies on the change of a single parameter, which is the time-
averaged distance between the N- and the C-terminus of the
p53 core. This parameter might not only change upon global
unfolding but might also respond to local alterations in the
structure. R248Q shows only a moderate destabilization of 1.9
kcal/mol and a majority of 86% was calculated to be folded at
37‡C. However, nuclear magnetic resonance spectroscopy re-
vealed local structural changes in the fold of this mutant
which might cause the observed increase in cleavage of the
corresponding Nvg-R248Q-Cub-Dha [20]. Furthermore, the as-
sumption that the cleavage ratio of Nvg-p53v-Cub-Dha will
serve as the universal reference for the denatured state might
not equally apply to all mutants. Recent studies showed that
denatured proteins could preserve a speci¢c structural signa-
ture [21^25]. Depending on the nature of the mutation the
conformation(s) of the denatured states might di¡er between
the p53 mutants leading to distinct cleavage ratios of the un-
folded proteins in the corresponding split-Ub fusions.
Despite these limitations the technique allowed to correctly
classify all the p53 mutations tested. R248Q and R273H are
DNA contact mutations and were shown to decrease the
stability of the core only very moderately. Both mutations
displayed compared to wild-type p53 either no change or
only a modest increase in cleavage of the corresponding
Nvg-p53C-Cub-Dha (Fig. 2). The N268D mutation does not
a¡ect the functions of p53 but instead leads to an increase
in stability by 31.22 kcal/mol [15]. This increase is re£ected by
the largest ratio of cleaved to uncleaved fusion protein in the
split-Ub assay (Fig. 2). In contrast C242S, R175H and V143A
are structural mutants leading to a compromised stability of
p53C. Accordingly all three mutants decrease the cleavage of
Nvg-p53-Cub-Dha at 37‡C leading to the predicted positive
value of relative destabilization (Fig. 2B).
A closer inspection of the relative destabilization values of
p53v, [C135Y; S240I] and V143A reveals a seeming inconsis-
tency. All three proteins appear more stable at 37‡C than at
30‡C (Fig. 2B). This interpretation is misleading since the
ratio of cleaved to uncleaved Nvg-p53-Cub-Dha decreases
from 77% to 52% as the temperature rises from 30‡C to
37‡C whereas the ratio is naturally much less reduced for
those mutants that are already signi¢cantly unfolded at
30‡C. The decrease in relative destabilization of those three
mutants therefore re£ects the increase in the population of
unfolded p53C at 37‡C rather than a stabilization of the mu-
tants.
Using the RUra3p reporter in the split-Ub assay I could
translate the di¡erence between wild-type core and V143A
into a read out that is based on growth of the transformed
cell on 5-FOA. Compounds that restore the stability of
V143A and penetrate the cell wall and the membrane of the
yeast should be able to restore the growth of the cells on this
medium. Based on the appearance of a £uorescent signal the
split-Ub compatible reporter RGFP might allow a similar
assay that will make possible the screening for p53 stabilizing
compounds in mammalian cells [26].
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